BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30160985)

  • 1. Characterizing Nebulizer Performance for Methacholine Challenge Tests.
    Coates A; Culver B; Cockcroft D; Hallstrand T; Haynes J; Kaminsky D; MacIntyre N; Wanger J
    Am J Respir Crit Care Med; 2018 Oct; 198(8):988-990. PubMed ID: 30160985
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulizer output for methacholine challenges with the KoKo Digidoser.
    Khan YR; McDonough P; Cockcroft DW; David BE; Hendeles L
    J Allergy Clin Immunol; 2005 Oct; 116(4):924-6. PubMed ID: 16210072
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of 2 dosimeters by methacholine challenge.
    Hendeles L; Khan YR; Shuster JJ; Spencer T
    J Allergy Clin Immunol; 2007 Nov; 120(5):1218-9. PubMed ID: 17637473
    [No Abstract]   [Full Text] [Related]  

  • 4. Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.
    Blais CM; Cockcroft DW; Veilleux J; Boulay MÈ; Boulet LP; Gauvreau GM; Scime TX; Watson RM; O'Byrne PM; Davis BE
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):88-93. PubMed ID: 28813613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methacholine Challenge Testing: A Novel Method for Measuring PD
    Davis BE; Simonson SK; Blais CM; Cockcroft DW
    Chest; 2017 Dec; 152(6):1251-1257. PubMed ID: 28923758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metered-dose inhaler to deliver methacholine in bronchial provocation testing: a pilot study.
    Roche N; El Husseini F; Labrune S; Giraud V; Chinet TC; Huchon GJ
    Chest; 1998 Jun; 113(6):1684-8. PubMed ID: 9631813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in nebulizer output and weight output from Mefar dosimeter: implications for multicentre studies.
    Ward RJ; Reid DW; Walters EH
    Eur Respir J; 1997 Oct; 10(10):2436-7. PubMed ID: 9387980
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose vs concentration in methacholine challenge.
    Donado CD
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):598. PubMed ID: 17601278
    [No Abstract]   [Full Text] [Related]  

  • 9. The correct methacholine challenge delivery method?
    Townley RG; Hopp RJ; Rosenthal RR
    J Allergy Clin Immunol; 2007 Apr; 119(4):1026-7; author reply 1027-9. PubMed ID: 17289132
    [No Abstract]   [Full Text] [Related]  

  • 10. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
    Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
    Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing alternative delivery systems for methacholine challenge tests.
    Coates AL; Leung K; Dell SD
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):66-70. PubMed ID: 23586502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging the two-minute tidal breathing challenge test.
    Lexmond AJ; Hagedoorn P; Frijlink HW; de Boer AH
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):380-6. PubMed ID: 23509936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methacholine bronchial challenge using a dosimeter with controlled tidal breathing.
    Nieminen MM; Lahdensuo A; Kellomaeki L; Karvonen J; Muittari A
    Thorax; 1988 Nov; 43(11):896-900. PubMed ID: 3065974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of oscillometry as a measure of airway responsiveness in asthmatic children after histamine and methacholine bronchoprovocation with dosimeter-MedicAid and DeVilbiss nebulizers.
    Kopriva F; Szotkowská J; Plocová A; Závodská J; Zápalka M; Smatanová D; Látalová M; Slezáková L; Radová L
    J Asthma; 2007 May; 44(4):267-71. PubMed ID: 17530524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma.
    El-Gammal AI; Killian KJ; Scime TX; Beaudin S; Schlatman A; Cockcroft DW; Gauvreau GM
    Ann Am Thorac Soc; 2015 Jul; 12(7):1039-43. PubMed ID: 25871542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lung deposition and biological effect of methacholine by use of a drying device for bronchial provocation tests.
    Malmberg P; Larsson K; Thunberg S
    Eur Respir J; 1991 Jul; 4(7):890-8. PubMed ID: 1955011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of methacholine inhalation challenge by a reservoir method.
    Wongtim S; Mogmud S; Chareonlap P; Phanuphak P
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):131-6. PubMed ID: 7612106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoprovocation methods: direct challenges.
    Cockcroft DW
    Clin Rev Allergy Immunol; 2003 Feb; 24(1):19-26. PubMed ID: 12644716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.